Measurement of natriuretic peptides at the point of care in the emergency and ambulatory setting: Current status and future perspectives

American Heart Journal

Volumn 166, Issue 4, 2013, Pages

  Bingisser, Roland ^a   Cairns, Charles B ^b   Christ, Michael ^c   Collinson, Paul ^d   Hausfater, Pierre ^e   Lindahl, Bertil ^f   Mair, Johannes ^g   Price, Christopher ^h   Venge, Per ⁱ  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c Laboratory Medicine and Transfusion Medicine   (Germany)

^d ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f UPPSALA UNIVERSITY   (Sweden)

^g INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^h UNIVERSITY OF OXFORD   (United Kingdom)

ⁱ UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; D DIMER; NATRIURETIC FACTOR; TROPONIN;

ACUTE HEART FAILURE; ADVERSE OUTCOME; AMBULATORY CARE; ANALYTICAL EQUIPMENT; ARTICLE; CARDIOVASCULAR RISK; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DYSPNEA; ECHOCARDIOGRAPHY; EMERGENCY CARE; HEALTH CARE DELIVERY; HEART FAILURE; HIGH RISK PATIENT; HOSPITAL INFORMATION SYSTEM; HOSPITAL READMISSION; HUMAN; OUTPATIENT; POINT OF CARE TESTING; PRACTICE GUIDELINE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW;

EID: 84885173742     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2013.06.012     Document Type: Review

References (65)

1. J.A. Ezekowitz, P. Kaul, and J.A. Bakal Trends in heart failure care: has the incident diagnosis of heart failure shifted from the hospital to the emergency department and outpatient clinics? Eur J Heart Fail 13 2011 142 147
2. N.L. Weintraub, S.P. Collins, and P.S. Pang Acute heart failure syndromes: emergency department presentation, treatment, and disposition: current approaches and future aims: a scientific statement from the American Heart Association Circulation 122 2010 1975 1996
3. Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 Eur Heart J 33 2012 1787 1847
4. K. Thygesen, J. Mair, and C. Mueller Recommendations for the use of natriuretic peptides in acute cardiac care: a position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care Eur Heart J 33 2011 2001 2006
5. R. Bingisser, C. Cairns, and M. Christ Cardiac troponin: a critical review of the case for point-of-care testing in the emergency department Am J Emerg Med 30 2012 1639 1649
6. J.L. Januzzi Jr., S.U. Rehman, and A.A. Mohammed Use of amino-terminal pro-B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction J Am Coll Cardiol 58 2011 1881 1889
7. S.R. Meisel, J.L. Januzzi, and M. Medvedovski Pre-admission NT-proBNP improves diagnostic yield and risk stratification - the NT-proBNP for EValuation of dyspnoeic patients in the Emergency Room and hospital (BNP4EVER) study Eur Heart J 2013 (advance publication online)
8. S.U. Rehman, A. Martinez-Rumayor, and T. Mueller Independent and incremental prognostic value of multimarker testing in acute dyspnea: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study Clin Chim Acta 392 2008 41 45
9. G. Prosen, P. Klemen, and M. Štrnad Combination of lung ultrasound (a comet-tail sign) and N-terminal pro-brain natriuretic peptide in differentiating acute heart failure from chronic obstructive pulmonary disease and asthma as cause of acute dyspnea in prehospital emergency setting Crit Care 15 2011 R114
10. A. Maisel, J.E. Hollander, and D. Guss Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath J Am Coll Cardiol 44 2004 1328 1333
11. H.G. Schneider, L. Lam, and A. Lokuge B-type natriuretic peptide testing, clinical outcomes, and health services use in emergency department patients with dyspnea: a randomized trial Ann Intern Med 150 2009 365 371
12. J.L. Januzzi Jr., C.A. Camargo, and S. Anwaruddin The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study Am J Cardiol 95 2005 948 954
13. L.L. Lam, P.A. Cameron, and H.G. Schneider Meta-analysis: effect of B-type natriuretic peptide testing on clinical outcomes in patients with acute dyspnea in the emergency setting Ann Intern Med 153 2010 728 735
14. L. Trinquart, P. Ray, and B. Riou Natriuretic peptide testing in EDs for managing acute dyspnea: a meta-analysis Am J Emerg Med 29 2011 757 767
15. S.A. Hunt, W.T. Abraham, and M.H. Chin 2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation Circulation 119 2009 e391 e479
16. W.H. Tang, G.S. Francis, and D.A. Morrow National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical utilization of cardiac biomarker testing in heart failure Circulation 116 2007 99 109
17. Heart Failure Society of America, Comprehensive Heart Failure Practice Guideline. http://www.heartfailureguideline.org/guideline-sections/41. Accessed May 2012.
18. E. Di Angelantonio, R. Chowdhury, and N. Sarwar B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies Circulation 120 2009 2177 2187
19. R.K. Rogers, G.J. Stoddard, and T. Greene Usefulness of adjusting for clinical covariates to improve the ability of B-type natriuretic peptide to distinguish cardiac from noncardiac dyspnea Am J Cardiol 104 2009 689 694
20. L.B. Daniels, P. Clopton, and V. Bhalla How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Results from the Breathing Not Properly Multinational Study Am Heart J 151 2006 999 1005
21. Roche Diagnostics. Elecsys proBNP package insert. 2003.
22. A.K. Roalfe, J. Mant, and J.A. Doust Development and initial validation of a simple clinical decision tool to predict the presence of heart failure in primary care: the MICE (Male, Infarction, Crepitations, Edema) rule Eur J Heart Fail 14 2012 1000 1008
23. M. Behnes, M. Brueckmann, and P. Ahmad-Nejad Diagnostic performance and cost effectiveness of measurements of plasma N-terminal pro brain natriuretic peptide in patients presenting with acute dyspnea or peripheral edema Int J Cardiol 135 2009 165 174
24. J.H. Rutten, E.W. Steyerberg, and F. Boomsma N-terminal pro-brain natriuretic peptide testing in the emergency department: beneficial effects on hospitalization, costs, and outcome Am Heart J 156 2008 71 77
25. C. Mueller, K. Laule-Kilian, and C. Schindler Cost-effectiveness of B-type natriuretic peptide testing in patients with acute dyspnea Arch Intern Med 166 2006 1081 1087
26. T. Breidthardt, K. Laule, and A.H. Strohmeyer Medical and economic long-term effects of B-type natriuretic peptide testing in patients with acute dyspnea Clin Chem 53 2007 1415 1422
27. M. Christ, K. Laule, and T. Klima Multimarker strategy for risk prediction in patients presenting with acute dyspnea to the emergency department Int J Cardiol 126 2008 73 78
28. M.J. Agterof, R.E. Schutgens, and R.J. Snijder Out of hospital treatment of acute pulmonary embolism in patients with a low NT-proBNP level J Thromb Haemost 8 2010 1235 1241
29. J.C. Kelder, M.R. Cowie, and T.A. McDonagh Quantifying the added value of BNP in suspected heart failure in general practice: an individual patient data meta-analysis Heart 97 2011 959 963
30. M. Onodera, M. Nakamura, and F. Tanaka Plasma B-type natriuretic peptide is useful for cardiovascular risk assessment in community-based diabetes subjects: comparison with albuminuria Int Heart J 53 2012 176 181
31. C. Adlbrecht, S. Neuhold, and M. Hülsmann NT-proBNP as a means of triage for the risk of hospitalisation in primary care Eur J Prev Cardiol 19 2012 55 61
32. R. Latini, S. Masson, and M. Wong Incremental prognostic value of changes in B-type natriuretic peptide in heart failure Am J Med 119 2006 70.e23 70.e30
33. G.M. Felker, V. Hasselblad, and A.F. Hernandez Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials Am Heart J 158 2009 422 430
34. P. Porapakkham, P. Porapakkham, and H. Zimmet B-type natriuretic peptide-guided heart failure therapy: a meta-analysis Arch Intern Med 170 2010 507 514
35. A.L. Bui, and G.C. Fonarow Home monitoring for heart failure management J Am Coll Cardiol 59 2012 97 104
36. S.M. Campbell, A. Fuat, and N. Summerton Diagnostic triage and the role of natriuretic peptide testing and echocardiography for suspected heart failure: an appropriateness ratings evaluation by UK GPs Br J Gen Pract 61 2011 e427 e435
37. J. Mant, J. Doust, and A. Roalfe Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care Health Technol Assess 13 2009 1 207
38. P.O. Collinson The cost effectiveness of B-Type natriuretic peptide measurement in the primary care setting-a UK perspective Congest Heart Fail 12 2006 103 107
39. T.K. Lim, G. Dwivedi, and S. Hayat Cost effectiveness of the B type natriuretic peptide, electrocardiography, and portable echocardiography for the assessment of patients from the community with suspected heart failure Echocardiography 24 2007 228 236
40. K. Shah, G.J. Terracciano, and K. Jiang Comparability of results between point-of-care and automated instruments to measure B-type natriuretic peptide West J Emerg Med 11 2010 44 48
41. A.S. Maisel, P. Krishnaswamy, and R.M. Nowak Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure N Engl J Med 347 2002 161 167
42. L.K. Morrison, A. Harrison, and P. Krishnaswamy Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea J Am Coll Cardiol 39 2002 202 209
43. R. Ro, H.C. Thode Jr., and M. Taylor Comparison of the diagnostic characteristics of two B-type natriuretic peptide point-of-care devices J Emerg Med 41 2011 661 667
44. A.J. Singer, R.H. Birkhahn, and D. Guss Rapid Emergency Department Heart Failure Outpatients Trial (REDHOT II): a randomized controlled trial of the effect of serial B-type natriuretic peptide testing on patient management Circ Heart Fail 2 2009 287 293
45. A.M. From, C.S. Lam, and S.R. Pitta Bedside assessment of cardiac hemodynamics: the impact of noninvasive testing and examiner experience Am J Med 124 2011 1051 1057
46. A.T. Limkakeng Jr., W. Drake, and G. Mani Left ventricular dysfunction screening in hypertensive patients with N-terminal pro-B-type natriuretic peptide and electrocardiogram Am J Emerg Med 30 2012 214 217
47. M. Zaninotto, M.M. Mion, and F. Di Serio PATHFAST NT-proBNP (N-terminal-pro B type natriuretic peptide): a multicenter evaluation of a new point-of-care assay Clin Chem Lab Med 48 2010 1029 1034
48. A.J. Hamilton, L.A. Swales, and J. Neill Risk stratification of chest pain patients in the emergency department by a nurse utilizing a point of care protocol Eur J Emerg Med 15 2008 9 15
49. E. Burri, K. Hochholzer, and N. Arenja B-type natriuretic peptide in the evaluation and management of dyspnoea in primary care J Intern Med 272 2012 504 513
50. Y. Tomonaga, F. Gutzwiller, and T.F. Lüscher Diagnostic accuracy of point-of-care testing for acute coronary syndromes, heart failure and thromboembolic events in primary care: a cluster-randomised controlled trial BMC Fam Pract 12 2011 12
51. C.P. Price, A. St John, and R.H. Christenson Testing at the point of care: errors of omission in a care pathway context Point Care 10 2011 182 185
52. M. Bradburn, S.W. Goodacre, and P. Fitzgerald Interhospital variation in the RATPAC trial (Randomised Assessment of Treatment using Panel Assay of Cardiac markers) Emerg Med J 29 2012 233 238
53. S.W. Goodacre, M. Bradburn, and E. Cross The Randomised Assessment of Treatment using Panel Assay of Cardiac Markers (RATPAC) trial: a randomised controlled trial of point-of-care cardiac markers in the emergency department Heart 97 2011 190 196
54. A. Zaphiriou, S. Robb, and T. Murray-Thomas The diagnostic accuracy of plasma BNP and NTproBNP in patients referred from primary care with suspected heart failure: results of the UK natriuretic peptide study Eur J Heart Fail 7 2005 537 541
55. Alere Triage® BNP Test. Available at http://www.alere.com/us/en/ product-details/triage-bnp-test.html. [Accessed January 2013].
56. L.K. Morrison, A. Harrison, and P. Krishnaswamy Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea J Am Coll Cardiol 39 2002 202 209
57. R. Ro, H.C. Thode Jr., and M. Taylor Comparison of the diagnostic characteristics of two B-type natriuretic peptide point-of-care devices J Emerg Med 41 2011 661 667
58. K. Shah, G.J. Terracciano, and K. Jiang Comparability of results between point-of-care and automated instruments to measure B-type natriuretic peptide West J Emerg Med 11 2010 44 48
59. Abbott Point of Care Web site. Available at: http://www. abbottpointofcare.com. Accessed January 2013.
60. M. Zaninotto, M.M. Mion, and F. Di Serio PATHFAST NT-proBNP (N-terminal-pro B type natriuretic peptide): a multicenter evaluation of a new point-of-care assay Clin Chem Lab Med 48 2010 1029 1034
61. Pathfast Immunoanalyzer Web site. http://www.pathfast.eu. [Accessed January 2013].
62. C. Zugck, M. Nelles, and H.A. Katus Multicentre evaluation of a new point-of-care test for the determination of NT-proBNP in whole blood Clin Chem Lab Med 44 2006 1269 1277
63. U. Alehagen, and M. Janzon A clinician's experience of using the Cardiac Reader NT-proBNP point-of-care assay in a clinical setting Eur J Heart Fail 10 2008 260 266
64. T. Bertsch, J.P. Chapelle, and C.E. Dempfle Multicentre analytical evaluation of a new point-of-care system for the determination of cardiac and thromboembolic markers Clin Lab 56 2010 37 49
65. E. Lee-Lewandrowski, J.L. Januzzi, and S.M. Green Multi-center validation of the Response Biomedical Corporation RAMP NT-proBNP assay with comparison to the Roche Diagnostics GmbH Elecsys proBNP assay Clin Chim Acta 386 2007 20 24